|
ZA811368B
(en)
|
1980-03-24 |
1982-04-28 |
Genentech Inc |
Bacterial polypedtide expression employing tryptophan promoter-operator
|
|
EP0207147A4
(en)
*
|
1984-12-21 |
1988-07-14 |
Techniclone Res Partners |
METHOD OF ELECTRICAL IMMORTALIZATION OF LYMPHOID CELLS.
|
|
DE3531430A1
(de)
|
1985-09-03 |
1987-03-05 |
Biotest Pharma Gmbh |
Verfahren zur gewinnung von komponenten aus einer fluessigkeit mit in raeumlich getrennten bereichen vorliegenden komponenten
|
|
US4963489A
(en)
*
|
1987-04-14 |
1990-10-16 |
Marrow-Tech, Inc. |
Three-dimensional cell and tissue culture system
|
|
US4900322A
(en)
|
1986-09-22 |
1990-02-13 |
Adams James D |
Blood component pooling valve and kit
|
|
US5476996A
(en)
*
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
|
US5399493A
(en)
|
1989-06-15 |
1995-03-21 |
The Regents Of The University Of Michigan |
Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
US5670617A
(en)
|
1989-12-21 |
1997-09-23 |
Biogen Inc |
Nucleic acid conjugates of tat-derived transport polypeptides
|
|
US5849288A
(en)
*
|
1990-01-15 |
1998-12-15 |
Yeda Research And Development Co. Ltd. |
Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
US6004811A
(en)
|
1991-03-07 |
1999-12-21 |
The Massachussetts General Hospital |
Redirection of cellular immunity by protein tyrosine kinase chimeras
|
|
US6753162B1
(en)
|
1991-03-07 |
2004-06-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
US5843728A
(en)
|
1991-03-07 |
1998-12-01 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
|
US5851828A
(en)
|
1991-03-07 |
1998-12-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
IL101147A
(en)
|
1991-03-07 |
2004-06-20 |
Gen Hospital Corp |
Redirection of cellular immunity by receptor chimeras
|
|
US5912170A
(en)
|
1991-03-07 |
1999-06-15 |
The General Hospital Corporation |
Redirection of cellular immunity by protein-tyrosine kinase chimeras
|
|
AU781922B2
(en)
|
1991-12-17 |
2005-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5289858A
(en)
|
1991-12-18 |
1994-03-01 |
Abbott Laboratories |
System for accommodating withdrawal of liquid from a bulk supply
|
|
US8211422B2
(en)
|
1992-03-18 |
2012-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric receptor genes and cells transformed therewith
|
|
DE69321962T2
(de)
|
1992-08-21 |
1999-07-01 |
Biogen Inc |
Von tat abgeleitete transportpolypeptide
|
|
US5580760A
(en)
|
1993-02-22 |
1996-12-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
FUSE binding protein and cDNA therefor
|
|
EP0710283A4
(en)
*
|
1993-07-22 |
1997-07-02 |
Merck & Co Inc |
THE EXPRESSION OF HUMAN INTERLEUKIN-1-g (b) IN A TRANSGENIC ANIMAL
|
|
US5599705A
(en)
|
1993-11-16 |
1997-02-04 |
Cameron; Robert B. |
In vitro method for producing differentiated universally compatible mature human blood cells
|
|
ES2204944T3
(es)
|
1994-03-03 |
2004-05-01 |
Alexion Pharmaceuticals, Inc. |
Genes y proteinas de fusion inhibidores del complemento terminal.
|
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
|
US6713247B1
(en)
*
|
1996-09-03 |
2004-03-30 |
Signal Pharmaceuticials, Inc. |
Human CNS cell lines and methods of use therefor
|
|
IL132941A0
(en)
|
1997-05-21 |
2001-03-19 |
Univ Leland Stanford Junior |
Composition and method for enhancing transport across biological membranes
|
|
EP0893493A3
(de)
*
|
1997-07-21 |
2002-12-04 |
Aventis Pharma Deutschland GmbH |
Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
|
|
GB9720585D0
(en)
*
|
1997-09-26 |
1997-11-26 |
Smithkline Beecham Biolog |
Vaccine
|
|
CA2314267A1
(en)
|
1997-12-10 |
1999-06-17 |
Washington University |
Anti-pathogen system and methods of use thereof
|
|
DE69923550T2
(de)
|
1998-04-08 |
2006-02-16 |
Shionogi & Co., Ltd. |
Verfahren um Vorläuferzellen von Osteoklasten zu isolieren und ihre Differenzierung in Osteoklasten zu induzieren.
|
|
US6835567B1
(en)
|
1998-04-14 |
2004-12-28 |
Signal Pharmaceuticals, Inc. |
PNS cell lines and methods of use therefor
|
|
US6451558B1
(en)
*
|
1998-08-03 |
2002-09-17 |
Novartis Ag |
Genes in the control of hematopoiesis
|
|
US6913925B1
(en)
*
|
1998-08-12 |
2005-07-05 |
Signal Pharmaceuticals Llc |
Human mesencephalon cell lines and methods of use therefor
|
|
EP1157275A4
(en)
|
1999-02-28 |
2003-01-15 |
Univ Washington |
NOVEL TRANSDUCTION MOLECULES AND METHODS OF USING THE SAME
|
|
WO2000059540A1
(en)
|
1999-04-05 |
2000-10-12 |
Biocrystal Ltd. |
Assay kits and methods for immune complex-mediated activation involving shed antigens
|
|
DE60031260T2
(de)
|
1999-04-12 |
2007-05-03 |
Heart Biosystems Gmbh |
Vorübergehend-immortalisierte zellen zur verwendung in gentherapie
|
|
US6451601B1
(en)
*
|
1999-04-12 |
2002-09-17 |
Modex Therapeutiques, S.A. |
Transiently immortalized cells for use in gene therapy
|
|
US6358739B1
(en)
|
1999-04-12 |
2002-03-19 |
Modex Therapeutiques, S.A. |
Transiently immortalized cells
|
|
US7135287B1
(en)
*
|
1999-10-02 |
2006-11-14 |
Biosite, Inc. |
Human antibodies
|
|
US7311920B1
(en)
*
|
1999-10-08 |
2007-12-25 |
University Of Maryland Biotechnology Institute |
Virus coat protein/receptor chimeras and methods of use
|
|
AU1482101A
(en)
*
|
1999-11-10 |
2001-06-06 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising renilla gfp
|
|
EP1103615A1
(en)
|
1999-11-25 |
2001-05-30 |
Universite De Geneve |
Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
|
|
US20010049393A1
(en)
*
|
1999-12-07 |
2001-12-06 |
Whitehead Institute For Biomedical Research |
Methods for defining MYC target genes and uses thereof
|
|
WO2001087058A1
(en)
*
|
2000-05-15 |
2001-11-22 |
Sonoko Habu |
Chimeric mouse having immunity constructed by using human cd34-positive cells and use thereof
|
|
US20020155127A1
(en)
|
2000-06-02 |
2002-10-24 |
Danher Wang |
Genetic vaccine against human immunodeficiency virus
|
|
US20030072794A1
(en)
*
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
US20070248618A1
(en)
*
|
2004-03-16 |
2007-10-25 |
Cohen David I |
Tat-Based vaccine Compositions and Methods of Making and Using Same
|
|
ATE428790T1
(de)
|
2000-09-25 |
2009-05-15 |
Genetronics Inc |
Verbessertes system zur regulation der transgenexpression
|
|
WO2002036738A2
(en)
|
2000-10-30 |
2002-05-10 |
Kalobios, Inc. |
Affinity maturation by competitive selection
|
|
AU2002228722B2
(en)
|
2000-11-01 |
2007-01-04 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Expression vectors able to elicit improved immune response and methods of using same
|
|
EP1338198B1
(en)
*
|
2000-12-01 |
2007-11-28 |
Central Institute For Experimental Animals |
Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse
|
|
WO2002057436A2
(en)
|
2001-01-19 |
2002-07-25 |
Gendel Limited |
Red blood cell from a transgenic animal as vehicle for polypeptide delivery
|
|
US7033744B2
(en)
*
|
2001-03-16 |
2006-04-25 |
Naoya Kobayashi |
Method for proliferating a liver cell, a liver cell obtained thereby, and use thereof
|
|
EP1397382B1
(en)
*
|
2001-05-31 |
2008-08-06 |
Novartis AG |
Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
|
|
EP1421115B1
(en)
|
2001-08-31 |
2005-03-02 |
Avidex Limited |
Soluble t cell receptor
|
|
CN1408850A
(zh)
*
|
2001-09-18 |
2003-04-09 |
王虹 |
人血树突状细胞永生化技术
|
|
CN100506978C
(zh)
|
2001-09-21 |
2009-07-01 |
中国人民解放军军事医学科学院野战输血研究所 |
一种新的造血干/祖细胞的富集方法及其体外定向诱导分化
|
|
GB0124391D0
(en)
|
2001-10-11 |
2001-11-28 |
Gene Expression Technologies L |
Control of gene expression
|
|
CA2466138A1
(en)
|
2001-11-02 |
2003-05-15 |
Shen Wu Wang |
B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
|
|
EP1321034A1
(en)
*
|
2001-12-21 |
2003-06-25 |
Pfizer Products Inc. |
Disruption of the phosphodieterase 10 gene
|
|
US7638325B2
(en)
|
2002-01-03 |
2009-12-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
US20030216315A1
(en)
|
2002-02-13 |
2003-11-20 |
Duke University |
Modulation of immune response by non-peptide binding stress response polypeptides
|
|
CN1240439C
(zh)
|
2002-03-28 |
2006-02-08 |
南京凯基生物科技发展有限公司 |
肿瘤基因开关药物
|
|
US7211191B2
(en)
|
2004-09-30 |
2007-05-01 |
Thermogenesis Corp. |
Blood component separation method and apparatus
|
|
EP1499180A4
(en)
|
2002-04-16 |
2006-09-13 |
Dana Farber Cancer Inst Inc |
CANCER MODELS
|
|
GB2387599B
(en)
|
2002-04-17 |
2005-08-10 |
Jason Peter Brown |
Methods for producing antibodies
|
|
CA2485363C
(en)
*
|
2002-05-10 |
2014-10-28 |
New Century Pharmaceuticals, Inc. |
Ferritin fusion proteins for use in vaccines and other applications
|
|
SI1506223T1
(sl)
|
2002-05-16 |
2006-04-30 |
Bavarian Nordic As |
Fuzijski protein HIV regulatornih/akcesorskih proteinov
|
|
EP1531666B1
(en)
*
|
2002-05-29 |
2013-10-23 |
Regeneron Pharmaceuticals, Inc. |
Inducible eukaryotic expression system
|
|
EP1545204B1
(en)
|
2002-09-06 |
2016-08-10 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
|
|
NZ539225A
(en)
|
2002-10-09 |
2006-09-29 |
Avidex Ltd |
Single chain recombinant T cell receptors
|
|
DE50209178D1
(de)
*
|
2002-10-11 |
2007-02-15 |
Imvision Gmbh |
Moduläre Antigen-Transporter Moleküle (MAT-Moleküle) zur Modulierung von Immunreaktionen, zugehörige Konstrukte, Verfahren und Verwendungen
|
|
AU2003274633A1
(en)
|
2002-10-15 |
2004-05-04 |
Ramot At Tel-Aviv University Ltd. |
Erythrocyte differentiation factor, gene encoding same, and methods of use thereof
|
|
ES2327229T3
(es)
|
2002-11-09 |
2009-10-27 |
Immunocore Ltd. |
Presentacion del receptor de linfocitos t.
|
|
JP2006509010A
(ja)
|
2002-12-05 |
2006-03-16 |
インペリアル・カレッジ・イノベイションズ・リミテッド |
アポトーシスの制御
|
|
GB0304068D0
(en)
|
2003-02-22 |
2003-03-26 |
Avidex Ltd |
Substances
|
|
US7482016B2
(en)
|
2003-03-19 |
2009-01-27 |
The J. David Gladstone Institutes |
Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides
|
|
DK1623017T3
(da)
|
2003-05-08 |
2011-01-10 |
Life Technologies Corp |
Frembringelse og isolering af antigenspecifikke T-celler
|
|
WO2005014785A2
(en)
|
2003-06-18 |
2005-02-17 |
The George Washington University |
Conditionally-immortalized hematopoietic progenitor cell lines
|
|
WO2005084158A2
(en)
*
|
2003-06-20 |
2005-09-15 |
The Regents Of The University Of California |
Polypeptide transduction and fusogenic peptides
|
|
IL161903A0
(en)
|
2003-07-17 |
2005-11-20 |
Gamida Cell Ltd |
Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs
|
|
US7705049B2
(en)
*
|
2004-01-21 |
2010-04-27 |
New York University |
Methods for treating non-melanoma cancers with PABA
|
|
JP2005232148A
(ja)
*
|
2004-02-03 |
2005-09-02 |
Technion Research & Development Foundation Ltd |
神経保護剤としてプロパルギルアミンの使用
|
|
JP4773434B2
(ja)
|
2004-05-19 |
2011-09-14 |
イムノコア リミテッド |
高親和性ｎｙ−ｅｓｏｔ細胞受容体
|
|
EP1756278B1
(en)
|
2004-05-19 |
2008-09-17 |
MediGene Ltd. |
Method of improving t cell receptors
|
|
US8361794B2
(en)
|
2004-06-29 |
2013-01-29 |
Immunocore Limited |
Cells expressing a modified T cell receptor
|
|
US20060068469A1
(en)
|
2004-08-17 |
2006-03-30 |
Research Development Foundation |
Bacterial vector systems
|
|
GB0420963D0
(en)
*
|
2004-09-21 |
2004-10-20 |
Reneuron Ltd |
Hepatocyte
|
|
WO2006045064A2
(en)
*
|
2004-10-20 |
2006-04-27 |
Whitehead Institute For Biomedical Research |
Cultured hematopoietic stem cells and method for expansion and analysis thereof
|
|
WO2007067183A1
(en)
|
2005-12-09 |
2007-06-14 |
The Regents Of The University Of California |
Derivation of unlimited quantities of neutrophils or monocyte/dendritic cells
|
|
US20060156422A1
(en)
*
|
2005-01-10 |
2006-07-13 |
Medical Research Council |
Methods and compositions for the generation of antibodies
|
|
JP2008535823A
(ja)
|
2005-03-25 |
2008-09-04 |
キュラジェン コーポレイション |
テネイシンの主要な抗原に対する抗体
|
|
CA2609342A1
(en)
|
2005-04-26 |
2006-11-02 |
Andrei L. Gartel |
Nucleoside compounds and methods of use thereof
|
|
EP1885754B1
(en)
|
2005-05-25 |
2011-02-09 |
Immunocore Ltd. |
T cell receptors which specifically bind to vygfvracl-hla-a24
|
|
CA2620364A1
(en)
*
|
2005-08-26 |
2007-03-01 |
David C. Yeomans |
Methods for treatment of headaches by administration of oxytocin
|
|
US20070047583A1
(en)
|
2005-08-29 |
2007-03-01 |
Siemens Aktiengesellschaft |
Method for using a short address in a packet header
|
|
KR101441693B1
(ko)
|
2005-10-18 |
2014-09-25 |
내셔날 쥬이쉬 헬스 |
조건부 불멸화 장기 줄기 세포 및 상기 세포의 제조 및사용 방법
|
|
JP4929288B2
(ja)
*
|
2005-11-04 |
2012-05-09 |
アルナイラム ファーマシューティカルズ， インコーポレイテッド |
Ｎａｖ１．８遺伝子の発現を抑制するための組成物および方法
|
|
EP1792627A1
(en)
|
2005-12-05 |
2007-06-06 |
ImVisioN AG |
Modulation of the immune response by administration of intralymphatic transduction allergen (ITAG-)-molecules
|
|
WO2008039818A2
(en)
|
2006-09-26 |
2008-04-03 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Modified t cell receptors and related materials and methods
|
|
WO2008038002A2
(en)
|
2006-09-29 |
2008-04-03 |
Medigene Limited |
T cell therapies
|
|
US8551968B2
(en)
|
2007-03-13 |
2013-10-08 |
National Jewish Health |
Methods for generation of antibodies
|
|
US20110218210A1
(en)
|
2007-11-02 |
2011-09-08 |
Taiga Biotechnologies |
Compounds for treating abnormal cellular proliferation
|
|
WO2009117439A2
(en)
|
2008-03-17 |
2009-09-24 |
The Scripps Research Institute |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
|
SG190661A1
(en)
*
|
2008-05-16 |
2013-06-28 |
Taiga Biotechnologies Inc |
Antibodies and processes for preparing the same
|
|
US8481492B2
(en)
|
2008-06-13 |
2013-07-09 |
Life & Brain Gmbh |
Fusion protein and use thereof
|
|
ES2525411T3
(es)
*
|
2008-07-21 |
2014-12-22 |
Taiga Biotechnologies, Inc. |
Células anucleadas diferenciadas y método para preparar las mismas
|
|
JP5812861B2
(ja)
|
2008-08-28 |
2015-11-17 |
タイガ バイオテクノロジーズ，インク． |
Ｍｙｃの修飾物質、該ｍｙｃの修飾物質を使用する方法、およびｍｙｃを調節する薬剤を同定する方法
|
|
CA3012803C
(en)
|
2008-11-06 |
2023-08-08 |
Indiana University Research & Technology Corporation |
Materials and methods to enhance hematopoietic stem cells engraftment procedures
|
|
CA2743669C
(en)
|
2008-11-24 |
2018-10-16 |
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh) |
High affinity t cell receptor and use thereof
|
|
WO2011100477A2
(en)
|
2010-02-10 |
2011-08-18 |
Taiga Biotechnologies, Inc. |
Antibodies and processes for preparing the same
|
|
US20120107317A1
(en)
|
2010-10-27 |
2012-05-03 |
The University Of Hong Kong |
Use of cytoplasmic c-myc for regulating immune responses
|
|
WO2012129201A1
(en)
|
2011-03-22 |
2012-09-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
|
|
EP3392270B1
(en)
|
2011-09-15 |
2020-08-26 |
The United States of America, as Represented by the Secretary Department of Health and Human Services |
T cell receptors recognizing hla-a1- or hla-cw7-restricted mage
|
|
US9751928B2
(en)
|
2012-05-03 |
2017-09-05 |
Fred Hutchinson Cancer Research Center |
Enhanced affinity T cell receptors and methods for making the same
|
|
DE102012209673A1
(de)
|
2012-06-08 |
2013-12-24 |
Artcline Gmbh |
Verfahren zum Herstellen einer Leukozytenpräparation und Leukozytenpräparation
|
|
SG11201500429QA
(en)
|
2012-07-20 |
2015-03-30 |
Taiga Biotechnologies Inc |
Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
|
|
CN104684926B
(zh)
|
2012-07-27 |
2022-04-08 |
伊利诺伊州大学理事会 |
工程化t细胞受体
|
|
US20140109246A1
(en)
|
2012-09-24 |
2014-04-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods of generating xenochimaeric mice with tumor and hematopoietic system from the same heterologous species
|
|
GB2508414A
(en)
|
2012-11-30 |
2014-06-04 |
Max Delbrueck Centrum |
Tumour specific T cell receptors (TCRs)
|
|
WO2014133568A1
(en)
|
2013-03-01 |
2014-09-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of producing enriched populations of tumor reactive t cells from peripheral blood
|
|
AU2013379772B2
(en)
|
2013-03-01 |
2018-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of producing enriched populations of tumor-reactive T cells from tumor
|
|
US10272115B2
(en)
|
2013-03-11 |
2019-04-30 |
Taiga Biotechnologies, Inc. |
Production and use of red blood cells
|
|
US9365825B2
(en)
|
2013-03-11 |
2016-06-14 |
Taiga Biotechnologies, Inc. |
Expansion of adult stem cells in vitro
|
|
CA2945393C
(en)
|
2014-04-24 |
2021-03-23 |
Board Of Regents, The University Of Texas System |
Application of induced pluripotent stem cells to generate adoptive cell therapy products
|
|
CN107427573B
(zh)
|
2014-12-24 |
2022-12-27 |
耐克西缪恩有限公司 |
用于免疫疗法的纳米颗粒组合物和方法
|
|
WO2017123978A1
(en)
|
2016-01-15 |
2017-07-20 |
Berkeley Lights, Inc. |
Methods of producing patient-specific anti-cancer therapeutics and methods of treatment therefor
|
|
US10149898B2
(en)
|
2017-08-03 |
2018-12-11 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|